Vitamin Shoppe Inc (VSI) Major Shareholder Buys $572,681.12 in Stock

Vitamin Shoppe Inc (NYSE:VSI) major shareholder Vintage Capital Management Llc acquired 133,804 shares of the business’s stock in a transaction on Tuesday, January 2nd. The shares were bought at an average price of $4.28 per share, with a total value of $572,681.12. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Vintage Capital Management Llc also recently made the following trade(s):

  • On Saturday, December 29th, Vintage Capital Management Llc acquired 234,343 shares of Vitamin Shoppe stock. The shares were bought at an average price of $4.36 per share, with a total value of $1,021,735.48.

Shares of Vitamin Shoppe Inc (VSI) traded down $0.10 on Wednesday, hitting $4.30. 506,856 shares of the stock traded hands, compared to its average volume of 534,050. Vitamin Shoppe Inc has a 12 month low of $2.95 and a 12 month high of $24.85. The company has a market capitalization of $105.50, a PE ratio of -0.41 and a beta of 0.68. The company has a debt-to-equity ratio of 0.59, a current ratio of 2.07 and a quick ratio of 0.32.

Vitamin Shoppe (NYSE:VSI) last announced its earnings results on Wednesday, November 8th. The specialty retailer reported ($0.03) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.17 by ($0.20). Vitamin Shoppe had a positive return on equity of 6.17% and a negative net margin of 20.27%. The business had revenue of $288.20 million for the quarter, compared to the consensus estimate of $297.61 million. During the same period in the prior year, the business posted $0.50 earnings per share. The firm’s revenue for the quarter was down 8.5% compared to the same quarter last year. sell-side analysts forecast that Vitamin Shoppe Inc will post 0.34 EPS for the current year.

Several brokerages have issued reports on VSI. ValuEngine upgraded shares of Vitamin Shoppe from a “hold” rating to a “buy” rating in a research report on Thursday, October 5th. Morgan Stanley restated an “equal weight” rating and set a $7.50 price objective (down from $8.00) on shares of Vitamin Shoppe in a research report on Monday, October 2nd. Zacks Investment Research raised shares of Vitamin Shoppe from a “sell” rating to a “hold” rating in a report on Wednesday, October 25th. Finally, Barclays lowered their target price on shares of Vitamin Shoppe from $6.00 to $3.00 and set an “equal weight” rating on the stock in a report on Thursday, November 9th. Four analysts have rated the stock with a sell rating and five have assigned a hold rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $5.00.

Institutional investors and hedge funds have recently made changes to their positions in the company. Schwab Charles Investment Management Inc. increased its holdings in shares of Vitamin Shoppe by 34.6% during the second quarter. Schwab Charles Investment Management Inc. now owns 262,123 shares of the specialty retailer’s stock worth $3,054,000 after purchasing an additional 67,362 shares during the period. GMT Capital Corp bought a new position in shares of Vitamin Shoppe during the third quarter worth approximately $3,423,000. Goldman Sachs Group Inc. increased its holdings in shares of Vitamin Shoppe by 88.5% during the second quarter. Goldman Sachs Group Inc. now owns 124,077 shares of the specialty retailer’s stock worth $1,445,000 after purchasing an additional 58,243 shares during the period. Legal & General Group Plc increased its holdings in shares of Vitamin Shoppe by 9.3% during the second quarter. Legal & General Group Plc now owns 44,555 shares of the specialty retailer’s stock worth $518,000 after purchasing an additional 3,789 shares during the period. Finally, Russell Investments Group Ltd. increased its stake in Vitamin Shoppe by 16.7% in the second quarter. Russell Investments Group Ltd. now owns 26,788 shares of the specialty retailer’s stock valued at $312,000 after acquiring an additional 3,839 shares during the last quarter. 90.35% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: “Vitamin Shoppe Inc (VSI) Major Shareholder Buys $572,681.12 in Stock” was first posted by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.americanbankingnews.com/2018/01/03/vitamin-shoppe-inc-vsi-major-shareholder-buys-572681-12-in-stock.html.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, direct and manufacturing. The retail segment includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats.

Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply